John P. Sharp, VP Finance and CFO at LIGAND PHARMACEUTICALS INC (LGND), sold 6,000 shares at $56.08 ($336K) on 2013-12-06, disclosed to the SEC on 2013-12-09.
Open-market sale of $336k LGND by VP Finance and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| LGND | SELL | 2013-12-16 | $37K | — | Filing → |
| LGND | SELL | 2013-11-20 | $60K | — | Filing → |
| LGND | SELL | 2013-08-20 | $321K | — | Filing → |